PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.07%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-34.65%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
822.03%
Gross profit growth 50-75% of CRON.TO's 1117.09%. Martin Whitman would scrutinize competitive position.
822.56%
Margin expansion 50-75% of CRON.TO's 1255.59%. Martin Whitman would scrutinize competitive position.
207.41%
R&D growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
-2.34%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-17.12%
Marketing expense reduction while CRON.TO shows 1.86% growth. Joel Greenblatt would examine competitive risk.
-21.03%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-11.69%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-26.23%
Both companies reducing total costs. Martin Whitman would check industry trends.
-74.43%
Both companies reducing interest expense. Martin Whitman would check industry trends.
10.45%
D&A growth while CRON.TO reduces D&A. John Neff would investigate differences.
70.35%
EBITDA growth 1.25-1.5x CRON.TO's 47.76%. Bruce Berkowitz would examine sustainability.
-99.75%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-112.41%
Operating income decline while CRON.TO shows 25.99% growth. Joel Greenblatt would examine position.
-112.42%
Operating margin decline while CRON.TO shows 15.91% growth. Joel Greenblatt would examine position.
-608.08%
Other expenses reduction while CRON.TO shows 107.60% growth. Joel Greenblatt would examine advantage.
87.31%
Pre-tax income growth exceeding 1.5x CRON.TO's 55.84%. David Dodd would verify competitive advantages.
87.30%
Pre-tax margin growth exceeding 1.5x CRON.TO's 49.82%. David Dodd would verify competitive advantages.
289.61%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
85.63%
Net income growth 1.25-1.5x CRON.TO's 75.58%. Bruce Berkowitz would examine sustainability.
85.62%
Net margin growth 1.25-1.5x CRON.TO's 72.25%. Bruce Berkowitz would examine sustainability.
86.67%
EPS growth 1.25-1.5x CRON.TO's 75.90%. Bruce Berkowitz would examine sustainability.
87.78%
Diluted EPS growth 1.25-1.5x CRON.TO's 75.90%. Bruce Berkowitz would examine sustainability.
11.12%
Share count reduction below 50% of CRON.TO's 1.06%. Michael Burry would check for concerns.
13.10%
Diluted share reduction below 50% of CRON.TO's 0.67%. Michael Burry would check for concerns.